Risk of movement disorders with antipsychotic drugs in patients with schizophrenia or depressive disorders
Objective: To compare the risk of movement disorders with antipsychotic drugs (APDs) in patients suffering from Schizophrenia or Depressive Disorders. Background: APDs are well-known causes…Comparative study of the substantia nigra echogenicity and 123-I ioflupane SPECT in patients with REM behavior disorder
Objective: To compare (1) the echogenicity of substantia nigra (SN) in subjects with idiopathic REM behavior disorder (iRBD) and healthy controls and (2) to determine…Frequency of echogenic abnormality of the substantia nigra is increased in methamphetamine users
Objective: To investigate structural abnormality of the substantia nigra (SN) in methamphetamine users using transcranial sonography (TCS). Background: Epidemiologic studies suggest that chronic use of…Manual MRI morphometry in Parkinsonian syndromes
Objective: We investigated a large sample of Parkinsonian patients and healthy controls from five German academic medical centers with 3D MP-RAGE sequences on mainly 3T…Extensive bilateral basal ganglia and cerebellar calcification in Fahr’s syndrome after thyroidectomy
Objective: To describe a patient with bilateral cerebral and cerebellar calcification secondary to a hypoparathyroidsm. Background: Fahr's Syndrome (FS) is a rare disorder and may…Children with intractable temporal and extratemporal seizures: Correlation of the MR spectroscopy and EEG findings in the surgical planning
Objective: To show the value of MR spectroscopy in detecting metabolite ratios dysfunction and in lateralizing the epileptogenic focus in agreement with EEG in children…Progressive ataxia and palatal tremor: A case report
Objective: To report a case of sporadic progressive ataxia and palatal tremor (PAPT). Background: PAPT is a rare disease with few case reports. It is…Evaluating the natural history of prodromal PD in the PARS cohort
Objective: An objective of the Parkinson Associated Risk Syndrome (PARS) study is to identify a cohort 'at risk' for Parkinson's disease (PD) using sequential olfactory…1-year clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes
Objective: To evaluate clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes (T2DM) 1-year after operation due to lower extremity artery disease (LEAD)…Tau dysfunction in the basal ganglia of a mouse model of tauopathy related to PSP
Objective: Determine motor coordination and neurochemical phenotypes in the basal ganglia of mice lacking the Tau protein or expressing an abnormal content of Tau isoforms.…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.